Article
Craniosynostosis in Children with X-Linked Hypophosphatemia Treated with Burosumab: Insights from a Single Center Cross-sectional Cohort Screening
2025-11-30
Abstract excerpt
<title>Abstract</title> <p> <bold>Background</bold> X-linked hypophosphatemic rickets (XLH) is the most common genetic form of hypophosphatemia, caused by elevated FGF23 and renal phosphate wasting. Cranial anomalies such as craniosynostosis (CS) and Chiari type I malformation (CM-I) are reported in XLH, but prevalence data—especially in the context of burosumab therapy—remain limited. This monocentric study ev...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 17743596-5103-5652-bfa1-40ce9726fa55
- DOI
- 10.21203/rs.3.rs-8107500/v1
